Since cyclooxygenase-2 (COX-2), the enzyme that produces prostanoids from arachidonic acid (AA), is well known to be associated to cell viability in several types of cancer [14], COX-2 has been studied as a useful therapeutic target for the treatment of various cancers [14, 15]. This evidence concerns the gene PTGS2 and cancer.